The effect was seen across a wide variety of addictive and habit-forming substances, including cocaine, opioids, alcohol, ...

Research is quickly catching up. In the last few years, studies have linked GLP-1 drugs like Ozempic and Wegovy with fewer ...

Al-Aly and his colleagues found that people starting the GLP-1 drugs had lower risks of developing addiction to multiple ...

New research suggests the weight-loss medications could be powerful tools in tackling substance use disorders.

My team and I set out to test whether GLP-1 drugs — medications like semaglutide (Ozempic and Wegovy) and tirzepatide (Mounjaro and Zepbound), originally developed for diabetes and then approved for ...

Weight-loss jabs could prevent and treat addiction to alcohol, cigarettes and drugs, according to a large study. Experts ...

GLP-1 medications may quiet the brain signals behind addiction, reducing substance use disorders and overdose risk across ...

A large epidemiological study of more than 600,000 veterans with diabetes suggests GLP-1 weight-loss medications may reduce ...

GLP-1 drugs, like semaglutide, may help people avoid developing addictions to alcohol, tobacco, and drugs such as cannabis ...

A large new study suggests they may drastically reduce the risk substance use disorders and drug-related deaths.

Evidence is mounting that the wildly popular weight-loss medicines known as GLP-1s may also hold potential for treating addiction, and the field may be on the verge of obtaining desperately needed ...